New York Life Trust’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
Other funds holding HOLX
New York Life Trust's HOLX Position: Q1 2017 in Review
New York Life Trust reduced its Hologic (HOLX) stake by 96% in Q1 2017, selling an estimated $106K and leaving 115 shares worth $5K. The position accounts for 0.24% of the portfolio, ranked #119.
New York Life Trust first reported a position in HOLX in Q3 2015 and has held it in 7 quarters since. The position peaked at $109K in Q4 2016. 501 funds tracked by Wall St. Rank hold HOLX as of Q1 2017.
- New York Life Trust held 115 shares of Hologic worth $5K as of Q1 2017.
- New York Life Trust sold 2,604 Hologic shares in Q1 2017, an estimated $106K.
- Hologic made up 0.24% of New York Life Trust's portfolio in Q1 2017, its #119 holding.
- New York Life Trust first reported a position in Hologic in Q3 2015 and has held it in 7 quarters since.
- New York Life Trust's Hologic position peaked at $109K in Q4 2016.
- 501 funds tracked by Wall St. Rank held Hologic as of Q1 2017.
Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.